Nature Communications

Daratumumab in high-risk MGUS and low-risk smoldering myeloma: results of the Phase II D-PRISM study

O Omar Nadeem M Michelle P. Aranha R Robert A. Redd M Michael Koontz J Jeffrey V. Matous (Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver) A Andrew J. Yee (Department of Medicine, Harvard Medical School, Boston) J Jeffrey A. Zonder A Andrew Kin S Sophie Magidson E Elizabeth D. Lightbody T Ting Wu (Children’s Hospital, Zhejiang University School of Medicine) F Floris Chabrun J Jean-Baptiste Alberge A Ankit K. Dutta J Jacqueline Perry A Ashlee Sturtevant M Mahshid Rahmat J Junko Tsuji C Christine Davie C Caroline Ricciardi F Frances Arters M Marjorie Marto A Amy Bergeron J Jacalyn Rosenblatt E Elizabeth K. O’Donnell T Tarek H. Mouhieddine (Icahn School of Medicine at Mount Sinai, New York) L Lorena Pantano J Jacob P. Laubach P Paul G. Richardson (Jerome Lipper Multiple Myeloma Center, Dana–Farber Cancer Institute, Harvard Medical School, Boston) G Gad Getz L Lorenzo Trippa (From Médecins Sans Frontières (L.G., F.V.), Sorbonne Université, INSERM Unité 1135, Centre d’Immunologie et des Maladies Infectieuses (L.G.), Assistance Publique–Hôpitaux de Paris, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié–Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (L.G.), and Epicentre (M.G., E. Baudin), Paris, and Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier Université de Montpellier, Montpellier, Institut de Recherche pour le Développement, Montpellier, INSERM, Montpellier (M.B.) — all in France; Interactive Development and Research, Singapore (U.K.); McGill University, Epidemiology, Biostatistics, and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis (G.E.V., P.N., P.P.J.P.) and the Division of HIV, Infectious Diseases, and Global Medicine (G.E.V.), University of California at San Francisco, San Francisco; the National Scientific Center of Phth...) R Romanos Sklavenitis-Pistofidis I Irene M. Ghobrial
Download PDF View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 17, Issue 1
Published April 08, 2026
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio
ISSN: 2041-1723 Open Access Life Sciences

Authors (33)

O

Omar Nadeem

M

Michelle P. Aranha

R

Robert A. Redd

M

Michael Koontz

J

Jeffrey V. Matous

Colorado Blood Cancer Institute and Sarah Cannon Research Institute, Denver

A

Andrew J. Yee

Department of Medicine, Harvard Medical School, Boston

J

Jeffrey A. Zonder

A

Andrew Kin

S

Sophie Magidson

E

Elizabeth D. Lightbody

T

Ting Wu

Children’s Hospital, Zhejiang University School of Medicine

F

Floris Chabrun

J

Jean-Baptiste Alberge

A

Ankit K. Dutta

J

Jacqueline Perry

A

Ashlee Sturtevant

M

Mahshid Rahmat

J

Junko Tsuji

C

Christine Davie

C

Caroline Ricciardi

F

Frances Arters

M

Marjorie Marto

A

Amy Bergeron

J

Jacalyn Rosenblatt

E

Elizabeth K. O’Donnell

T

Tarek H. Mouhieddine

Icahn School of Medicine at Mount Sinai, New York

L

Lorena Pantano

J

Jacob P. Laubach

P

Paul G. Richardson

Jerome Lipper Multiple Myeloma Center, Dana–Farber Cancer Institute, Harvard Medical School, Boston

G

Gad Getz

L

Lorenzo Trippa

From Médecins Sans Frontières (L.G., F.V.), Sorbonne Université, INSERM Unité 1135, Centre d’Immunologie et des Maladies Infectieuses (L.G.), Assistance Publique–Hôpitaux de Paris, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié–Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux (L.G.), and Epicentre (M.G., E. Baudin), Paris, and Translational Research on HIV and Endemic and Emerging Infectious Diseases, Montpellier Université de Montpellier, Montpellier, Institut de Recherche pour le Développement, Montpellier, INSERM, Montpellier (M.B.) — all in France; Interactive Development and Research, Singapore (U.K.); McGill University, Epidemiology, Biostatistics, and Occupational Health, Montreal (U.K.); UCSF Center for Tuberculosis (G.E.V., P.N., P.P.J.P.) and the Division of HIV, Infectious Diseases, and Global Medicine (G.E.V.), University of California at San Francisco, San Francisco; the National Scientific Center of Phth...

R

Romanos Sklavenitis-Pistofidis

I

Irene M. Ghobrial

Related Articles from this Journal

Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization

Chao Wu, Xu Zhang et al. Aug 2026 10.1038/s41467-026-76516-1

Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses

Connor Weidle, Natalie Brunette et al. Aug 2026 10.1038/s41467-026-76114-1

Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

Ludmila Prokunina-Olsson, Oscar Florez-Vargas et al. Aug 2026 10.1038/s41467-026-76157-4

Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants

Weiwei Jin, Wen Cao et al. Aug 2026 10.1038/s41467-026-76470-y

Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain

Bongmin Bae, Katherine Gu et al. Aug 2026 10.1038/s41467-026-76506-3